Suppr超能文献

高敏 C 反应蛋白预测原发性高血压患者微量白蛋白尿的进展:一项为期 3 年的随访研究。

High-sensitivity C-reactive protein predicts microalbuminuria progression in essential hypertensive patients: a 3-year follow-up study.

机构信息

Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.

Laboratory of Vascular Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

出版信息

Blood Press Monit. 2024 Oct 1;29(5):242-248. doi: 10.1097/MBP.0000000000000713. Epub 2024 Jun 21.

Abstract

OBJECTIVES

To determine the independent effect of high-sensitivity C-reactive protein (hs-CRP) and the combined effects of hs-CRP and other traditional risk factors on microalbuminuria in hypertensive patients during the 3-year follow-up period.

METHODS AND RESULTS

Baseline hs-CRP levels and other risk factors were measured in 280 adults in 2007. In the third year of examination, 199 patients (mean age 62.5 ± 9.5, men 59.3%) were approached for the measurement of microalbuminuria. The subjects were classified into two groups by the median of baseline hs-CRP. Compared to the patients with baseline hs-CRP below the median group ( n  = 99, 50%), the group with baseline hs-CRP above the median ( n  = 100, 50%) had higher urinary albumin-to-creatinine ratio (ACR) ( P  = 0.007) at the end of follow-up period. ACR at the end of follow-up period was significantly correlated with baseline diabetes ( β  = 0.342; P  < 0.001), baseline SBP ( β  = 0.148; P  = 0.02), and baseline log-transformed hs-CRP ( β  = 0.169; P  = 0.01), while adversely correlated with baseline estimated glomerular filtration rate (eGFR) ( β  = -0.163; P  = 0.02) in multivariate stepwise linear analysis. In addition, ACR change during follow-up period was significantly correlated with baseline diabetes ( β  = 0.359; P  < 0.001) and baseline log-transformed hs-CRP ( β  = 0.190; P  = 0.004) in multivariate stepwise linear analysis. The combined effects of baseline hs-CRP and conventional risk factors, such as male sex, diabetes, smoking status, hyperlipidemia, hyperuricemia, and mildly reduced eGFR had a greater risk for microalbuminuria progression. There was no difference in eGFR changes during the follow-up period between two groups.

CONCLUSION

Our findings offer a new piece of evidence on the predictive value of baseline hs-CRP for microalbuminuria progression in essential hypertensive patients, and highlight those who combined with traditional cardiovascular risk factors had a greater risk for developing microalbuminuria.

摘要

目的

确定高敏 C 反应蛋白(hs-CRP)的独立作用,以及 hs-CRP 和其他传统危险因素联合对高血压患者在 3 年随访期间微量白蛋白尿的影响。

方法和结果

2007 年对 280 例成年人进行了基线 hs-CRP 水平和其他危险因素的测量。在第 3 年检查时,对 199 例患者(平均年龄 62.5±9.5 岁,男性占 59.3%)进行了微量白蛋白尿的检测。根据基线 hs-CRP 的中位数将受试者分为两组。与基线 hs-CRP 低于中位数组( n =99,50%)相比,基线 hs-CRP 高于中位数组( n =100,50%)的患者在随访期末的尿白蛋白/肌酐比值(ACR)更高( P =0.007)。随访期末的 ACR 与基线糖尿病( β =0.342; P <0.001)、基线收缩压( β =0.148; P =0.02)和基线对数 hs-CRP( β =0.169; P =0.01)显著相关,而与基线估算肾小球滤过率(eGFR)呈负相关( β =-0.163; P =0.02)。多元逐步线性分析显示,在随访期间 ACR 的变化与基线糖尿病( β =0.359; P <0.001)和基线对数 hs-CRP( β =0.190; P =0.004)显著相关。基线 hs-CRP 与传统危险因素(如男性、糖尿病、吸烟状况、血脂异常、高尿酸血症和轻度降低的 eGFR)的联合作用对微量白蛋白尿进展的风险更大。两组在随访期间的 eGFR 变化无差异。

结论

本研究结果为基线 hs-CRP 对原发性高血压患者微量白蛋白尿进展的预测价值提供了新的证据,并强调了那些同时合并传统心血管危险因素的患者发生微量白蛋白尿的风险更大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验